A prospective, randomized, multi-center trial to investigate Actovegin in prevention and treatment of acute oral mucositis caused by chemoradiotherapy for nasopharyngeal carcinoma

Published:September 09, 2010DOI:https://doi.org/10.1016/j.radonc.2010.08.003

      Abstract

      Purpose

      A multi-center prospective randomized trial was conducted to evaluate the efficacy and safety of Actovegin in the prevention and treatment of chemoradiotherapy-induced acute oral mucositis.

      Methods and materials

      Between February 2006 and May 2007, 156 evaluable patients with nasopharyngeal carcinoma were randomized to Group 1 (n = 53) for prevention, Group 2 (n = 51) for treatment, and Group 3 (n = 52) for control. All patients received concomitant chemoradiotherapy ± induction chemotherapy. Radiation technique and dose were similar among 3 groups. Intravenous Actovegin of 30 ml daily (5 days/week) was administrated from day 1 of the radiotherapy for Group 1 and from the onset of grade 2 mucositis for Group 2, until the end of the radiotherapy.

      Results

      The incidence of grade 3 mucositis was lower in Group 1 compared with Group 3 (26.4% vs. 55.8%, P=0.002). Group 2 had a lower progression rate of mucositis from grade 2 to 3 compared with Group 3 (39.2% vs. 60.4%, P=0.035). There was no difference in the onset time of grade 3 mucositis among 3 groups. Actovegin was well tolerated and no treatment-related adverse events were observed.

      Conclusions

      Actovegin is effective in the prevention and treatment of chemoradiotherapy-induced oral mucositis.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic and Personal
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Radiotherapy and Oncology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Smichmidt-Ullrich R.K.
        • Johnson C.
        • Wazer D.E.
        • et al.
        Accelerated superfractionated irradiation for advanced carcinoma of head and neck: concomitant boost technique.
        Int J Radiat Oncol Biol Phys. 1991; 21: 563-568
        • Pinto L.H.J.
        • Canary P.C.V.
        • Araujo C.M.M.
        • et al.
        Prospective randomized trial comparing hyperfractioned versus conventional radiotherapy in stages III and IV oropharyngeal carcinoma.
        Int J Radiat Oncol Biol Phys. 1991; 21: 557-562
        • Horiot J.C.
        • Le Fur R.
        • N’Guyen T.
        • et al.
        Hyperfractionation versus conventional fractionation in oropharingeal carcinoma: final analysis of a randomized trial of the EORTC cooperative group of radiotherapy.
        Radiother Oncol. 1992; 25: 231-241
        • Merlano M.
        • Corvo R.
        • Margarino G.
        • et al.
        Combined chemotherapy and radiation therapy in advanced inoperable squamous cell carcinoma of the head and neck: the final report of a randomized trial.
        Cancer. 1991; 67: 914-921
        • Browman G.P.
        • Cripps C.
        • Hodson D.I.
        • et al.
        Placebo controlled randomized trial of infusion flourouracil during standard radiotherapy in locally advanced head and neck cancer.
        J Clin Oncol. 1994; 12: 2648-2653
        • Bachaud J.M.
        • David J.M.
        • Boussin G.
        • et al.
        Combined post-operative radiotherapy and weekly cisplatin infusion for locally advanced squamous cell carcinoma of the head and neck: preliminary report of a randomized trial.
        Int J Radiat Oncol Biol Phys. 1991; 20: 243-246
        • Taylor S.G.
        • Murthy A.K.
        • Vannetzel J.M.
        • et al.
        Randomized comparison of neoadjuvant cisplatin and fluorouracil infusion followed by radiation versus concomitant treatment in advanced head and neck cancer.
        J Clin Oncol. 1994; 12: 385-395
        • Trotti A.
        Toxicity in head and neck cancer: a review of trends and issues.
        Int J Radiat Oncol Biol Phys. 2000; 47: 1-12
        • List M.A.
        • Siston A.
        • Haraf D.
        • et al.
        Quality of life and performance in advanced head and neck cancer patients on concomitant chemoradiotherapy: a prospective examination.
        J Clin Oncol. 1999; 17: 1020-1028
        • Terrell J.E.
        • Ronis D.L.
        • Fowler K.E.
        • et al.
        Clinical predictors of quality of life in patients with head and neck cancer.
        Arch Otolaryngol Head Neck Surg. 2004; 130: 401-408
        • Plevová P.
        Prevention and treatment of chemotherapy- and radiotherapy-induced oral mucositis: a review.
        Oral Oncol. 1999; 35: 453-470
        • Sinka L.
        • Hlavatý P.
        Clinical experiences with treatment of ulcus cruris.
        Fortsch Med. 1973; 91: 959-961
        • Zhang X.C.
        • Xiao F.
        • Wei L.C.
        • et al.
        Clinical study of the effect of Actovegin in the prevention of acute irradiation oropharyngeal mucositis.
        J Pract Stomatol. 2006; 22: 496-498
        • Jensen M.P.
        • Karoly P.
        Self-report scales and procedures for assessing pain in adults.
        in: Turk D.C. Melzack R. Handbook of pain assessment. Guildford Press, New York1992: 135-152
        • Sonis S.
        Mucositis as a biological process: a new hypothesis for the development of chemotherapy-induced stomatotoxicity.
        Oral Oncol. 1998; 34: 39-43
        • Sonis S.
        • Edwards L.
        • Lucey C.
        The biological basis for the attenuation of mucositis: the example of interleukin-11.
        Leukemia. 1999; 13: 831-834
        • Planting A.S.
        • Catimel G.
        • de Mulder P.H.
        • et al.
        Randomized study of a short course of weekly cisplatin with or without amifostine in advanced head and neck cancer. EORTC Head and Neck Cooperative Group.
        Ann Oncol. 1999; 10: 693-700
        • Sonis S.
        • Clark J.
        Prevention and management of oral mucositis induced by antineoplastic therapy.
        Oncology. 1991; 5: 11-18
        • Trotti A.
        • Bellm L.A.
        • Epstein J.B.
        • et al.
        Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review.
        Radiother Oncol. 2003; 66: 253-262
        • Scully C.
        • Epstein J.
        • Sonis S.
        Oral mucositis: a challenging complication of radiotherapy, chemotherapy, and radiochemotherapy. Part 2: Diagnosis and management of mucositis.
        Head Neck. 2004; 26: 77-84
        • Baujat B.
        • Audry H.
        • Bourhis J.
        • et al.
        Chemotherapy in locally advanced nasopharyngeal carcinoma: an individual patient data meta-analysis of eight randomized trials and 1753 patients.
        Int J Radiat Oncol Biol Phys. 2006; 64: 47-56
        • Wang H.P.
        • Sun Y.C.
        • Jin S.W.
        • et al.
        Clinical application and evaluation of Actovegin.
        Anhui Prev Med Mar. 2000; 6: 158-159
        • Wang X.J.
        • Chang B.C.
        Observation of therapeutic efficacy of Actovegin, Methycobal and Raceanisodamine on diabetic neuropathy.
        J Tianjin Med Univ. 2004; 10: 209-211
        • Yu H.R.
        • Xiao J.Y.
        • Liu Y.Z.
        • et al.
        The clinical efficacy of deproteinized calf blood injection in treatment of acute cerebral infarction.
        Chin New Drugs J. 2000; 9: 401-402
        • Barth G.
        • Graebner H.F.
        • Lotz H.
        The treatment of lethal radiation damage with Actihaemyl in animal experiments.
        Strahlentherapie Arch Klin Exp Radiol. 1969; 138: 714-723
        • Hoefer-Janker H.
        • Scheef W.
        • Dockter J.
        The action of an extract of calf’s blood on radiation-induced lesions of the mucuous of the laryngo-pharyngeal region.
        Strahlentherapie Arch Klin Exp Radiol. 1970; 139: 701-708
        • Bauer K.M.
        Local treatment of the urinary bladder damaged by radiation.
        Med Welt. 1970; 21: 790-792
        • Heinrich W.
        The treatment of exudative radiodermatitis with Actihaemyl cream.
        Fortschr Med. 1969; 18: 807
        • Gruia V.D.
        • Bayerl J.R.
        Treatment of radiation-produced arm plexus pareses with Actovegin.
        Fortschr Med. 1981; 99: 161-162
        • Martin M.V.
        Irradiation mucositis: a reappraisal.
        Oral Oncol Eur J Cancer. 1993; 29B: l-2
        • Hui P.S.
        • Cowan W.T.
        • Ko F.
        • et al.
        Effects of granulocyte-macrophage colony-stimulating factor on wound contraction.
        Eur J Clin Microbial Infect Dis. 1994; 13: 41-46
        • Carnel S.B.
        • Blakeslee D.B.
        • Oswald S.G.
        • et al.
        Treatment of radiation and chemotherapy-induced stomatitis.
        Otolaryngol Head Neck Surg. 1990; 102: 326-330
        • Spijkervet K.L.
        • Van Saene H.K.F.
        • Van Saene J.J.M.
        • et al.
        Effect of selective elimination of the oral flora on mucositis in irradiated head and neck cancer patients.
        J Surg Oncol. 1991; 46: 167-173
        • Armstrong T.S.
        Stomatitis in the bone marrow transplant patient: an overview and proposed oral care protocol.
        Cancer Nurs. 1994; 17: 403-410
        • Spijkervet F.K.L.
        • Van Saene H.K.F.
        • Panders A.K.
        • et al.
        Effect of chlorhexidine rinsing on the oropharyngeal ecology in patients with head and neck cancer who have irradiation mucositis.
        Oral Surg Oral Med Oral Pathol. 1989; 67: 154-161
        • Ferretti A.G.
        • Raybould T.B.
        • Brown A.T.
        • et al.
        Chlorhexidene prophylaxis for chemotherapy- and radiotherapy-induced stomatitis: a randomized double-blind trial.
        Oral Surg Oral Med Oral Pathol. 1990; 69: 331-338
        • Eissner G.
        • Lindner H.
        • Behrends U.
        • et al.
        Influence of bacterial endotoxin on radiation-induced activation of human endothelial cells in vitro and in vivo: protective role of IL-10.
        Transplantation. 1996; 62: 819-827
        • Fritzsche W.
        Promotion of tumor-ulcer healing by means of a protein-free calf blood extract.
        Zeitschrift für Haut u Geschlechtskrankheiten. 1961; 8: 235-238